Innovations in tubular tissue engineering, treating pain, fabrication of soft machines, quantum metrology, human genome editing, and more

Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs

Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes

Innovations in the synthesis of tetracycline antibiotics, readying blood stem cells for transplantation, CRISPR systems, microfluidics, cancer vaccines, soft robotics, and more